Evidence map›Paper›PMID 26052450›Full record

ReviewSultan Qaboos University medical journal2015

The Burden of Asthma in Oman.

Nasser Al-Busaidi, Zulfikar Habibulla, Malvika Bhatnagar, Nabil Al-Lawati, Yaqoub Al-Mahrouqi

Abstract readReview
In one paragraph

Review in Sultan Qaboos University medical journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Over-prescription of short-acting βAsthma research and practice · 2022
    Article
  7. Article
  8. The prevalence of childhood asthma in Saudi Arabia.International journal of pediatrics & adolescent medicine · 2019
    Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nasser Al-BusaidiDepartment of Medicine, Respiratory Unit and, Royal Hospital, Muscat, Oman.
Zulfikar HabibullaDepartment of Medicine, Respiratory Unit and, Royal Hospital, Muscat, Oman.
Malvika BhatnagarInternal Medicine Unit, Royal Hospital, Muscat, Oman.
Nabil Al-LawatiDepartment of Medicine, Respiratory Unit and, Royal Hospital, Muscat, Oman.
Yaqoub Al-MahrouqiDepartment of Medicine, Respiratory Unit and, Royal Hospital, Muscat, Oman.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Asthma is a common lung disease worldwide, although its prevalence varies from country to country. Oman is ranked in the intermediate range based on results from the International Study of Asthma and Allergies in Childhood. A 2009 study revealed that the majority of asthmatic patients in Oman reported both daytime and nocturnal symptoms, while 30% of adults and 52% of children reported absences from work or school due to their symptoms. Despite these findings, there is little data available on the economic burden of asthma in Oman. The only accessible information is from a 2013 study which concluded that Oman's highest asthma-related costs were attributable to inpatient (55%) and emergency room (25%) visits, while asthma medications contributed to less than 1% of the financial toll. These results indicate a low level of asthma control in Oman, placing a large economic burden on healthcare providers. Therefore, educating asthmatic patients and their families should be prioritised in order to improve the management and related costs of this disease within Oman.

Indexed as

AsthmaBurden of IllnessEconomic Burden of DiseaseLung DiseasesOman

Identifiers

PMID26052450
PMCPMC4450780

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.